Skip to main content
. Author manuscript; available in PMC: 2013 Mar 15.
Published in final edited form as: J Immunol. 2012 Feb 10;188(6):2669–2676. doi: 10.4049/jimmunol.1100529

Figure 7. Th9-induced AHR is significantly reduced by treatment with sialoL.

Figure 7

Rag1−/− mice were adoptively transferred with Th9 cells developed from DO11.10 mice and challenged with nebulized OVA in the absence or presence of sialoL as outlined in Materials and Methods and (A). Airway resistance (B) was measured in mice 24h after a final airway challenge on day 7. Bars represent mean ±SEM AHR; * p<0.05 compared to Th9 and Th9/chall + SialoL.